Sporos News

Sporos Bioventures Appoints Amit Rakhit, M.D. as Chief Executive Officer

HOUSTON, Texas., September 29, 2021 — Sporos Bioventures, LLC, a private biotechnology company catalyzing the rapid development of breakthrough therapies through a portfolio of companies that target novel disease mechanisms in cancer, fibrosis, inflammation, and immune-related diseases, today announced the appointment of Amit Rakhit, M.D., M.B.A. as chief executive officer. Dr. Rakhit joins Sporos from …

Sporos Bioventures Appoints Amit Rakhit, M.D. as Chief Executive Officer Read More »

Sporos Launches with $38.1 Million Series A Financing

Company intends to develop and extend its diverse pipeline of therapies for cancer and immune diseases, beginning with four entities Leadership team includes founding chief financial officer Michael Wyzga, formerly of Genzyme HOUSTON, Texas., May 6, 2021— Sporos Bioventures, LLC (the “Company” or “Sporos”), officially launched today with the close of a $38.1 million Series …

Sporos Launches with $38.1 Million Series A Financing Read More »

Scroll to Top